Probing the Role of Connecting Bonds and Modifying Chains in the Rational Design of Prodrug Nanoassemblies

ACS Appl Mater Interfaces. 2022 Nov 16;14(45):51200-51211. doi: 10.1021/acsami.2c14523. Epub 2022 Nov 3.

Abstract

Prodrug-based self-assembled nanoparticles combined with the merits of nanotechnology and prodrugs strategies have gradually become a research trending topic in the field of drug delivery. These prodrugs usually consist of parent drugs, connecting bonds, and modifying chains. The influences of the connecting bonds and modifying chains on the pharmaceutical characteristics, in vivo delivery fate, and antitumor activity of prodrug nanoassemblies remain elusive. Herein, three docetaxel (DTX) prodrugs were designed using sulfur bonds (thioether bond or disulfide bond) as connecting bonds and fatty alcohols (straight chain or branched chain) as modifying chains. Interestingly, the difference between connecting bonds and modifying chains deeply influenced the colloidal stability, redox responsive drug release, cytotoxicity, pharmacokinetic properties, tumor accumulation, and antitumor effect of prodrug nanoassemblies. DTX conjugated with branched chain fatty alcohols via disulfide bonds (HUA-SS-DTX) significantly improved the antitumor efficiency of DTX and reduced the systematic toxicity. Our study elaborates on the vital role of connecting bonds and modifying chains in the rational design of prodrug nanoassemblies.

Keywords: disulfide bond; fatty alcohol; prodrug; redox-responsive; thioether bond.

MeSH terms

  • Cell Line, Tumor
  • Disulfides / chemistry
  • Docetaxel
  • Fatty Alcohols
  • Prodrugs* / chemistry

Substances

  • Prodrugs
  • Docetaxel
  • Disulfides
  • Fatty Alcohols